Iksuda Therapeutics enters license agreement with University of Goettingen to develop a new generation of antibody drug conjugates

By |2020-11-04T10:20:31+00:00October 13th, 2020|News|

Iksuda Therapeutics enters license agreement with University of Goettingen to develop a new generation

Comments Off on Iksuda Therapeutics enters license agreement with University of Goettingen to develop a new generation of antibody drug conjugates

Ground Breaking cancer diagnostics spin out that looks to save up to 2,000 lives each year joins Newcastle Helix eco-system

By |2020-11-04T10:21:44+00:00October 7th, 2020|News|

The Biosphere, a specialist lab facility on Newcastle Helix, has welcomed yet another Newcastle

Comments Off on Ground Breaking cancer diagnostics spin out that looks to save up to 2,000 lives each year joins Newcastle Helix eco-system
Go to Top